The 6R's of drug induced nephrotoxicity

被引:123
作者
Awdishu, Linda [1 ,2 ]
Mehta, Ravindra L. [2 ]
机构
[1] Univ Calif San Diego, Skaggs Sch Pharm, San Diego, CA 92093 USA
[2] Univ Calif San Diego, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA
关键词
Nephrotoxicity; Acute kidney injury; Drugs; Hypersensitivity; Adverse reaction; Tubular toxicity; Nephrolithiasis; Glomerular; Crystalluria; ACUTE KIDNEY INJURY; CONTRAST-INDUCED NEPHROPATHY; CRITICALLY-ILL PATIENTS; HIV-INFECTED PATIENTS; VANCOMYCIN-ASSOCIATED NEPHROTOXICITY; TENOFOVIR DISOPROXIL FUMARATE; ACUTE INTERSTITIAL NEPHRITIS; GLOMERULAR-FILTRATION-RATE; PROTON PUMP INHIBITORS; ACUTE-RENAL-FAILURE;
D O I
10.1186/s12882-017-0536-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
100201 [内科学]; 100221 [泌尿外科学];
摘要
Drug induced kidney injury is a frequent adverse event which contributes to morbidity and increased healthcare utilization. Our current knowledge of drug induced kidney disease is limited due to varying definitions of kidney injury, incomplete assessment of concurrent risk factors and lack of long term outcome reporting. Electronic surveillance presents a powerful tool to identify susceptible populations, improve recognition of events and provide decision support on preventative strategies or early intervention in the case of injury. Research in the area of biomarkers for detecting kidney injury and genetic predisposition for this adverse event will enhance detection of injury, identify those susceptible to injury and likely mitigate risk. In this review we will present a 6R framework to identify and mange drug induced kidney injury-risk, recognition, response, renal support, rehabilitation and research.
引用
收藏
页数:12
相关论文
共 126 条
[1]
RANDOMIZED, DOUBLE-BLIND COMPARISON OF CIPROFLOXACIN AND TRIMETHOPRIM-SULFAMETHOXAZOLE FOR COMPLICATED URINARY-TRACT INFECTIONS [J].
ALLAIS, JM ;
PREHEIM, LC ;
CUEVAS, TA ;
ROCCAFORTE, JS ;
MELLENCAMP, MA ;
BITTNER, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (09) :1327-1330
[2]
Antoniou Tony, 2015, CMAJ Open, V3, pE166, DOI 10.9778/cmajo.20140074
[3]
How to Optimize Drug Delivery in Renal Replacement Therapy [J].
Awdishu, Linda ;
Bouchard, Josee .
SEMINARS IN DIALYSIS, 2011, 24 (02) :176-182
[4]
The ATTAIN trials: efficacy and safety of telavancin compared with vancomycin for the treatment of hospital-acquired and ventilator-associated bacterial pneumonia [J].
Barriere, Steven L. .
FUTURE MICROBIOLOGY, 2014, 9 (03) :281-289
[5]
Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the Phase 3 ATTAIN studies [J].
Barriere, Steven L. ;
Stryjewski, Martin E. ;
Corey, G. Ralph ;
Genter, Fredric C. ;
Rubinstein, Ethan .
BMC INFECTIOUS DISEASES, 2014, 14
[6]
Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity [J].
Beger, Richard D. ;
Sun, Jinchun ;
Schnackenberg, Laura K. .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2010, 243 (02) :154-166
[7]
Betton Graham R., 2005, Cancer Biomarkers, V1, P59
[8]
A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use [J].
Blank, Mei-Ling ;
Parkin, Lianne ;
Paul, Charlotte ;
Herbison, Peter .
KIDNEY INTERNATIONAL, 2014, 86 (04) :837-844
[9]
Relationship between Vancomycin Trough Concentrations and Nephrotoxicity: a Prospective Multicenter Trial [J].
Bosso, John A. ;
Nappi, Jean ;
Rudisill, Celeste ;
Wellein, Marlea ;
Bookstaver, P. Brandon ;
Swindler, Jenna ;
Mauldin, Patrick D. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (12) :5475-5479
[10]
PREVALENCE, PATHOGENESIS, AND TREATMENT OF RENAL DYSFUNCTION ASSOCIATED WITH CHRONIC LITHIUM-THERAPY [J].
BOTON, R ;
GAVIRIA, M ;
BATLLE, DC .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1987, 10 (05) :329-345